Literature DB >> 15916802

Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants.

Aude Motulsky1, Michel Lafleur, Anne-Claude Couffin-Hoarau, Didier Hoarau, Frank Boury, Jean-Pierre Benoit, Jean-Christophe Leroux.   

Abstract

The development of simple and efficient drug delivery systems for the sustained release of peptides/proteins and low molecular weight hydrophilic molecules is an ongoing challenge. The purpose of this work was to prepare and characterize novel biodegradable in situ-forming implants obtained via the self-assembly of L-alanine derivatives in pharmaceutical oils. Six different amphiphilic organogelators based on L-alanine were synthesized. These derivatives could successfully gel various vegetable and synthetic oils approved for parenteral administration. Gelation was thermoreversible, and phase transition temperatures depended on gelator structure, concentration and solvent. Hydrogen bonds and van der Waals interactions were shown to be the main forces implicated in network formation. Selected formulations were then injected subcutaneously in rats for preliminary assessment of biocompatibility. Histopathological analysis of the surrounding tissues revealed mild, chronic inflammation and an overall good biocompatibility profile of the implants over the 8 wk evaluation period. This study demonstrates that in situ-forming organogels represent a potentially promising platform for sustained drug delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916802     DOI: 10.1016/j.biomaterials.2005.04.004

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  7 in total

1.  Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease.

Authors:  Guillaume Bastiat; François Plourde; Aude Motulsky; Alexandra Furtos; Yvan Dumont; Rémi Quirion; Gregor Fuhrmann; Jean-Christophe Leroux
Journal:  Biomaterials       Date:  2010-05-15       Impact factor: 12.479

2.  Synthesis, Characterization and Biocompatibility of N-palmitoyl L-alanine-based Organogels as Sustained Implants of Granisetron and Evaluation of thier Antiemetic Effect.

Authors:  Hala Bakr El-Nassan; Aliaa Nabil ElMeshad; Walaa Wadie; Rabab H Sayed
Journal:  Pharm Res       Date:  2018-05-29       Impact factor: 4.200

3.  Genetically engineered block copolymers: influence of the length and structure of the coiled-coil blocks on hydrogel self-assembly.

Authors:  Chunyu Xu; Jindrich Kopecek
Journal:  Pharm Res       Date:  2007-08-23       Impact factor: 4.200

4.  Pharmaceutical organogels prepared from aromatic amino acid derivatives.

Authors:  Guillaume Bastiat; Jean-Christophe Leroux
Journal:  J Mater Chem       Date:  2009-04-28

5.  In situ-forming oleogel implant for rivastigmine delivery.

Authors:  Anda Vintiloiu; Michel Lafleur; Guillaume Bastiat; Jean-Christophe Leroux
Journal:  Pharm Res       Date:  2007-08-12       Impact factor: 4.200

6.  A Peptide Amphiphile Organogelator of Polar Organic Solvents.

Authors:  Charlotte K Rouse; Adam D Martin; Christopher J Easton; Pall Thordarson
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

7.  Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections.

Authors:  Yang Wu; Zhiyong Song; Huajuan Wang; Heyou Han
Journal:  Nat Commun       Date:  2019-10-02       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.